Literature DB >> 29025055

Frozen embryo transfer: a review on the optimal endometrial preparation and timing.

S Mackens1, S Santos-Ribeiro1,2, A van de Vijver1, A Racca1,3, L Van Landuyt1, H Tournaye1, C Blockeel1,4.   

Abstract

STUDY QUESTION: What is the optimal endometrial preparation protocol for a frozen embryo transfer (FET)? SUMMARY ANSWER: Although the optimal endometrial preparation protocol for FET needs further research and is yet to be determined, we propose a standardized timing strategy based on the current available evidence which could assist in the harmonization and comparability of clinic practice and future trials. WHAT IS KNOWN ALREADY: Amid a continuous increase in the number of FET cycles, determining the optimal endometrial preparation protocol has become paramount to maximize ART success. In current daily practice, different FET preparation methods and timing strategies are used. STUDY DESIGN, SIZE, DURATION: This is a review of the current literature on FET preparation methods, with special attention to the timing of the embryo transfer. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Literature on the topic was retrieved in PubMed and references from relevant articles were investigated until June 2017. MAIN RESULTS AND THE ROLE OF CHANCE: The number of high quality randomized controlled trials (RCTs) is scarce and, hence, the evidence for the best protocol for FET is poor. Future research should compare both the pregnancy and neonatal outcomes between HRT and true natural cycle (NC) FET. In terms of embryo transfer timing, we propose to start progesterone intake on the theoretical day of oocyte retrieval in HRT and to perform blastocyst transfer at hCG + 7 or LH + 6 in modified or true NC, respectively. LIMITATIONS REASONS FOR CAUTION: As only a few high quality RCTs on the optimal preparation for FET are available in the existing literature, no definitive conclusion for benefit of one protocol over the other can be drawn so far. WIDER IMPLICATIONS OF THE
FINDINGS: Caution when using HRT for FET is warranted since the rate of early pregnancy loss is alarmingly high in some reports. STUDY FUNDING/COMPETING INTEREST(S): S.M. is funded by the Research Fund of Flanders (FWO). H.T. and C.B. report grants from Merck, Goodlife, Besins and Abbott during the conduct of the study. TRIAL REGISTRATION NUMBER: Not applicable.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  IVF-ICSI outcome; endometrium; frozen embryo transfer; infertility; receptivity; window of implantation

Mesh:

Year:  2017        PMID: 29025055     DOI: 10.1093/humrep/dex285

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  50 in total

1.  [Effect of serum estradiol level before progesterone administration on pregnancy outcomes of frozen-thawed embryo transfer cycles].

Authors:  Ling Deng; Xin Chen; De-Sheng Ye; Shi-Ling Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

2.  "Universal Warming" protocol for vitrified oocytes to streamline cell exchange for transnational donation programs: a multi-center study.

Authors:  Lodovico Parmegiani; M G Minasi; A Arnone; V Casciani; G E Cognigni; R Viñoles; M T Varricchio; L A Quintero; E Greco; M Filicori
Journal:  J Assist Reprod Genet       Date:  2020-05-03       Impact factor: 3.412

3.  Comparison of perinatal outcomes between spontaneous vs. commissioned cycles in gestational carriers for single and same-sex male intended parents.

Authors:  Z Pavlovic; K C Hammer; M Raff; P Patel; K N Kunze; B Kaplan; C Coughlin; J Hirshfeld-Cytron
Journal:  J Assist Reprod Genet       Date:  2020-03-04       Impact factor: 3.412

4.  The impact of euploid blastocyst morphology and maternal age on pregnancy and neonatal outcomes in natural cycle frozen embryo transfers.

Authors:  Wendy Y Zhang; Jasmyn K Johal; Rebecca M Gardner; Brindha Bavan; Amin A Milki
Journal:  J Assist Reprod Genet       Date:  2022-02-05       Impact factor: 3.412

5.  Progesterone and estrogen levels are associated with live birth rates following artificial cycle frozen embryo transfers.

Authors:  Ronit Beck-Fruchter; Simon Nothman; Shira Baram; Yoel Geslevich; Amir Weiss
Journal:  J Assist Reprod Genet       Date:  2021-09-18       Impact factor: 3.412

6.  Perinatal outcomes of neonates born from different endometrial preparation protocols after frozen embryo transfer: a retrospective cohort study.

Authors:  Cheng Li; Yi-Chen He; Jing-Jing Xu; Yu Wang; Han Liu; Chen-Chi Duan; Chao-Yi Shi; Lei Chen; Jie Wang; Jian-Zhong Sheng; He-Feng Huang; Yan-Ting Wu
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-29       Impact factor: 3.007

7.  Day 5 vitrified blastocyst transfer versus day 6 vitrified blastocyst transfer in oocyte donation program.

Authors:  G M Yerushalmi; T Shavit; S Avraham; M Youngster; A Kedem; I Gat; U S Dorofeyeva; S Mashiach; E Schiff; A Shulman; D S Seidman; A Wiser; E Maman; A Hourvitz; M Baum
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

8.  Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study.

Authors:  Yuval Atzmon; Nardin Aslih; Daniela Estrada; Asaf Bilgory; Adrian Ellenbogen; Einat Shalom-Paz
Journal:  Reprod Sci       Date:  2020-11-02       Impact factor: 3.060

Review 9.  Letrozole for Female Infertility.

Authors:  Ai-Min Yang; Na Cui; Yi-Fei Sun; Gui-Min Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

10.  Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.

Authors:  Raoul Orvieto; Christos A Venetis; Human M Fatemi; Thomas D'Hooghe; Robert Fischer; Yulia Koloda; Marcos Horton; Michael Grynberg; Salvatore Longobardi; Sandro C Esteves; Sesh K Sunkara; Yuan Li; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.